Skip to content

Clinical trials

Phase 2 Diabetes Mellitus trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 2 Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20112
20151
20171
20211
20221
20232
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status6
Completed2
Not yet recruiting2
Terminated2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Supreme Life Pharmaceutical Technology Co., Ltd.1
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1
Fudan University1
GlaxoSmithKline1
Guangdong Provincial People's Hospital1
Guizhou Bailing Group Pharmaceutical Co Ltd1
Haibo Shao1
Hejiang Ye1
Lu jin ,MD1
Shanghai Jiao Tong University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus14
Diabetes Mellitus, Type 26
Diabetes Mellitus, Type 12
Diabetic Retinopathy2
Insulin Resistance2
Autoimmune Diseases1
Carcinoma, Hepatocellular1
Cognitive Dysfunction1
Neuralgia1
Obesity1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.